N-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)-3-pyridinyl)phenyl)carbamic acid phenylmethyl ester is a pharmaceutical intermediate for the synthesis of Torezolid (Tedizolid) used to treat acute bacterial Skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria.
Thiourea modified polyacrylnitrile fibers as efficient Pd(II) scavengers.[1]
Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity.[2]
References:
[1] J.Cao, et al, RSC Adv., 2016, 63, pp 58088-58089.
-3-pyridinyl)phenyl)carbamic_acid_phenylmethyl_ester.png)
